Qiong Duan
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Nutrient-driven histone acetylation underlies energy storage and mobilization.
Journal: Molecular metabolism
Published: December 05, 2025
ALYREF inhibits ferroptosis in vascular endothelial cells and improves atherosclerosis by epigenetic modification of CISD1.
Journal: Clinical epigenetics
Published: April 28, 2025
Adipose tissue-specific Yap knockout exacerbates diet-induced obesity through suppression of lipolysis.
Journal: Molecular and cellular endocrinology
Published: December 20, 2024
Distinct effects of physical and functional ablation of brown adipose tissue on T3-dependent pathological cardiac remodeling.
Journal: Biochemical and biophysical research communications
Published: September 24, 2024
Atorvastatin reduces renal interstitial fibrosis caused by unilateral ureteral obstruction through inhibiting the transcriptional activity of YAP.
Journal: Biochemical and biophysical research communications
Published: July 21, 2023
Roles of Bromodomain Extra Terminal Proteins in Metabolic Signaling and Diseases.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 11, 2022
PlGF Reduction Compromises Angiogenesis in Diabetic Foot Disease Through Macrophages.
Journal: Frontiers in immunology
Published: July 04, 2021
Brd4 participates in epigenetic regulation of the extinction of remote auditory fear memory.
Journal: Neurobiology of learning and memory
Published: September 22, 2020
BET proteins inhibitor JQ-1 impaired the extinction of remote auditory fear memory: An effect mediated by insulin like growth factor 2.
Journal: Neuropharmacology
Published: March 27, 2020
BET bromodomain inhibition suppresses adipogenesis in mice.
Journal: Endocrine
Published: July 13, 2019
Bromodomain-containing protein 4 contributes to renal fibrosis through the induction of epithelial-mesenchymal transition.
Journal: Experimental cell research
Published: May 21, 2019
Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
Journal: Biochemical and biophysical research communications
Published: March 17, 2019
Last Updated: 09/26/2026